IUHSA
Itau Unibanco Holding S.A. Portfolio holdings
AUM
$2.63B
1-Year Return
21.65%
This Quarter Return
-1.74%
1 Year Return
+21.65%
3 Year Return
+79.74%
5 Year Return
+135.75%
10 Year Return
–
AUM
$3.2B
AUM Growth
+$169M
(+5.6%)
Cap. Flow
+$258M
Cap. Flow
% of AUM
8.05%
Top 10 Holdings %
Top 10 Hldgs %
57.99%
Holding
441
New
116
Increased
148
Reduced
92
Closed
76
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$250M |
| 2 |
Credicorp
BAP
|
$206M |
| 3 |
Petrobras
PBR
|
$198M |
| 4 |
NVIDIA
NVDA
|
$41.1M |
| 5 |
America Movil
AMX
|
$40.3M |
Top Sells
| 1 |
iShares 10-20 Year Treasury Bond ETF
TLH
|
$119M |
| 2 |
TSMC
TSM
|
$112M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
$111M |
| 4 |
Coca-Cola Femsa
KOF
|
$68.3M |
| 5 |
Vale
VALE
|
$65M |
Sector Composition
| 1 | Financials | 17.35% |
| 2 | Energy | 13.4% |
| 3 | Technology | 11.63% |
| 4 | Communication Services | 9.21% |
| 5 | Consumer Discretionary | 4.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Garmin
GRMN
$45.7B
| $44.1K | ﹤0.01% |
214
-8
| -4% | -$1.65K |
|
252
Deckers Outdoor
DECK
$17.9B
| $44.1K | ﹤0.01% |
217
+169
| +352% | +$34.3K |
|
253
Fastenal
FAST
$54.8B
| $43.9K | ﹤0.01% |
1,222
+1,012
| +482% | +$36.4K |
|
|
PGRE
254
Paramount Group
PGRE
$1.65B
| $43.8K | ﹤0.01% |
4,191
+2,474
| +144% | +$25.9K |
|
255
Bristol-Myers Squibb
BMY
$95.6B
| $43.7K | ﹤0.01% |
772
-310
| -29% | -$17.5K |
|
256
BioMarin Pharmaceuticals
BMRN
$11.1B
| $43.6K | ﹤0.01% |
663
+90
| +16% | +$5.92K |
|
257
Edwards Lifesciences
EW
$47.4B
| $43.5K | ﹤0.01% |
588
-189
| -24% | -$14K |
|
258
D.R. Horton
DHI
$54.1B
| $43.5K | ﹤0.01% |
+311
| New | +$43.5K |
|
259
Abbott
ABT
$232B
| $43.3K | ﹤0.01% |
+383
| New | +$43.3K |
|
260
Merck
MRK
$211B
| $43.3K | ﹤0.01% |
435
-76
| -15% | -$7.56K |
|
261
Boston Scientific
BSX
$158B
| $43.1K | ﹤0.01% |
+483
| New | +$43.1K |
|
262
Coupang
CPNG
$52.5B
| $43K | ﹤0.01% |
1,955
+1,640
| +521% | +$36K |
|
263
Danaher
DHR
$144B
| $42.7K | ﹤0.01% |
186
-58
| -24% | -$13.3K |
|
264
Eli Lilly
LLY
$654B
| $42.5K | ﹤0.01% |
55
-37
| -40% | -$28.6K |
|
265
Republic Services
RSG
$71.5B
| $42.4K | ﹤0.01% |
211
+25
| +13% | +$5.03K |
|
266
Roku
ROKU
$14.1B
| $42.3K | ﹤0.01% |
569
+278
| +96% | +$20.7K |
|
267
Biogen
BIIB
$20.8B
| $42.2K | ﹤0.01% |
276
+45
| +19% | +$6.88K |
|
268
Thermo Fisher Scientific
TMO
$185B
| $42.1K | ﹤0.01% |
81
-28
| -26% | -$14.6K |
|
269
Moderna
MRNA
$9.84B
| $42.1K | ﹤0.01% |
1,013
+343
| +51% | +$14.3K |
|
270
LPL Financial
LPLA
$27B
| $42.1K | ﹤0.01% |
+129
| New | +$42.1K |
|
271
Snap-on
SNA
$17.1B
| $42.1K | ﹤0.01% |
3,908
+2,257
| +137% | +$24.3K |
|
272
Waters Corp
WAT
$18.2B
| $41.9K | ﹤0.01% |
113
-73
| -39% | -$27.1K |
|
273
SiriusXM
SIRI
$8.03B
| $41.9K | ﹤0.01% |
1,838
+1,321
| +256% | +$30.1K |
|
274
Stryker
SYK
$149B
| $41.8K | ﹤0.01% |
+116
| New | +$41.8K |
|
275
Bio-Rad Laboratories Class B
BIO.B
| $41.7K | ﹤0.01% |
+127
| New | +$41.7K |
|